SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-14-002926
Filing Date
2014-09-24
Accepted
2014-09-24 17:23:17
Documents
3
Period of Report
2014-09-23
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ecte8ksept242014.htm 8-K 36336
2 PRESS RELEASE ISSUED BY THE COMPANY ON SEPTEMBER 23, 2014 ex99-1.htm EX-99.1 13586
3 logo.jpg GRAPHIC 15554
  Complete submission text file 0001415889-14-002926.txt   73021
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35218 | Film No.: 141119041
SIC: 3845 Electromedical & Electrotherapeutic Apparatus